These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20680325)

  • 1. Cortical excitability in very mild Alzheimer's disease: a long-term follow-up study.
    Olazarán J; Prieto J; Cruz I; Esteban A
    J Neurol; 2010 Dec; 257(12):2078-85. PubMed ID: 20680325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation.
    Padovani A; Benussi A; Cantoni V; Dell'Era V; Cotelli MS; Caratozzolo S; Turrone R; Rozzini L; Alberici A; Altomare D; Depari A; Flammini A; Frisoni GB; Borroni B
    J Alzheimers Dis; 2018; 65(1):221-230. PubMed ID: 30010131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment.
    Di Lorenzo F; Motta C; Casula EP; Bonnì S; Assogna M; Caltagirone C; Martorana A; Koch G
    Brain Stimul; 2020; 13(5):1175-1182. PubMed ID: 32485235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability.
    Pennisi G; Ferri R; Lanza G; Cantone M; Pennisi M; Puglisi V; Malaguarnera G; Bella R
    J Neural Transm (Vienna); 2011 Apr; 118(4):587-98. PubMed ID: 21207079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D₂-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients.
    Martorana A; Di Lorenzo F; Esposito Z; Lo Giudice T; Bernardi G; Caltagirone C; Koch G
    Neuropharmacology; 2013 Jan; 64():108-13. PubMed ID: 22863599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.
    Di Lazzaro V; Oliviero A; Pilato F; Saturno E; Dileone M; Marra C; Daniele A; Ghirlanda S; Gainotti G; Tonali PA
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):555-9. PubMed ID: 15026495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.
    Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V
    Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia.
    Benussi A; Di Lorenzo F; Dell'Era V; Cosseddu M; Alberici A; Caratozzolo S; Cotelli MS; Micheli A; Rozzini L; Depari A; Flammini A; Ponzo V; Martorana A; Caltagirone C; Padovani A; Koch G; Borroni B
    Neurology; 2017 Aug; 89(7):665-672. PubMed ID: 28747446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    Mimura Y; Nishida H; Nakajima S; Tsugawa S; Morita S; Yoshida K; Tarumi R; Ogyu K; Wada M; Kurose S; Miyazaki T; Blumberger DM; Daskalakis ZJ; Chen R; Mimura M; Noda Y
    Neurosci Biobehav Rev; 2021 Feb; 121():47-59. PubMed ID: 33307047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical excitability and plasticity in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of transcranial magnetic stimulation studies.
    Chou YH; Sundman M; Ton That V; Green J; Trapani C
    Ageing Res Rev; 2022 Aug; 79():101660. PubMed ID: 35680080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of event-related potentials in cognitive decline in Alzheimer's disease.
    Lai CL; Lin RT; Liou LM; Liu CK
    Clin Neurophysiol; 2010 Feb; 121(2):194-9. PubMed ID: 20005164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in thresholds for intracortical excitability in chronic stroke: more than just altered intracortical inhibition.
    Edwards JD; Meehan SK; Linsdell MA; Borich MR; Anbarani K; Jones PW; Ferris J; Boyd LA
    Restor Neurol Neurosci; 2013; 31(6):693-705. PubMed ID: 23963339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study.
    Julkunen P; Jauhiainen AM; Westerén-Punnonen S; Pirinen E; Soininen H; Könönen M; Pääkkönen A; Määttä S; Karhu J
    J Neurosci Methods; 2008 Jul; 172(2):270-6. PubMed ID: 18533272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological differences in cortical excitability in different forms of dementia: A transcranial magnetic stimulation and laboratory biomarkers study.
    Khedr EM; Ahmed OG; Sayed HM; Abo-Elfetoh N; Ali AM; Gomaa AM
    Neurophysiol Clin; 2020 Jul; 50(3):185-193. PubMed ID: 32591186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into Alzheimer's disease progression: a combined TMS and structural MRI study.
    Niskanen E; Könönen M; Määttä S; Hallikainen M; Kivipelto M; Casarotto S; Massimini M; Vanninen R; Mervaala E; Karhu J; Soininen H
    PLoS One; 2011; 6(10):e26113. PubMed ID: 22022529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease.
    Nardone R; Tezzon F; Höller Y; Golaszewski S; Trinka E; Brigo F
    Acta Neurol Scand; 2014 Jun; 129(6):351-66. PubMed ID: 24506061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity.
    Alagona G; Bella R; Ferri R; Carnemolla A; Pappalardo A; Costanzo E; Pennisi G
    Neurosci Lett; 2001 Nov; 314(1-2):57-60. PubMed ID: 11698146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Cognition and Cortical Excitability in Huntington's Disease.
    Kamble N; Netravathi M; Nagaraju BC; Lenka A; Kumar K; Sowmya V; Jain S; Pal PK
    Can J Neurol Sci; 2018 Mar; 45(2):176-181. PubMed ID: 29307324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher motor cortical excitability linked to greater cognitive dysfunction in Alzheimer's disease: results from two independent cohorts.
    Zadey S; Buss SS; McDonald K; Press DZ; Pascual-Leone A; Fried PJ
    Neurobiol Aging; 2021 Dec; 108():24-33. PubMed ID: 34479168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.